Neurocognitive function after radiotherapy for paediatric brain tumours

Nature Reviews Neurology

Volumn 8, Issue 10, 2012, Pages 578-588

  Padovani, Laetitia ^a   André, Nicolas ^a   Constine, Louis S ^a   Muracciole, Xavier ^b  

^a TIMONE HOSPITAL   (France)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYTARABINE; DONEPEZIL; FENOFIBRATE; GLUCOCORTICOID; LITHIUM; MELATONIN; METHOTREXATE; METHYLPHENIDATE; MODAFINIL; PLACEBO; PSYCHOSTIMULANT AGENT;

AGE DISTRIBUTION; ALZHEIMER DISEASE; ATTENTION DEFICIT DISORDER; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN EDEMA; BRAIN RADIATION; BRAIN SIZE; BRAIN TUMOR; CANCER GRADING; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID SHUNTING; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; COGNITIVE REHABILITATION; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DOSIMETRY; DRUG MEGADOSE; GENOMICS; GRAY MATTER; HIGH RISK POPULATION; HUMAN; HUNTINGTON CHOREA; HYDROCEPHALUS; INTENSITY MODULATED RADIATION THERAPY; KINESIOTHERAPY; LEARNING DISORDER; MEDULLOBLASTOMA; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROANATOMY; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOGENOMICS; REHABILITATION CARE; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SKULL IRRADIATION; SLEEP DISORDER; STEM CELL TRANSPLANTATION; SYNAPTIC POTENTIAL; WHITE MATTER INJURY;

ANIMALS; BRAIN NEOPLASMS; CHILD; COGNITION; COGNITION DISORDERS; CRANIAL IRRADIATION; HUMANS; NERVE FIBERS, MYELINATED; NEURONAL PLASTICITY;

EID: 84872300522     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.182     Document Type: Review

References (134)

1. Pollack, I. F. & Jakacki, R. I. Childhood brain tumors: epidemiology, current management and future directions. Nat. Rev. Neurol. 7, 495-501 (2011).
2. Goldsby, R. E. et al. Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 28, 324-331 (2010).
3. Sands, S. A. et al. Long-term follow-up of children treated for high-grade gliomas: Children's Oncology Group L991 final study report. J. Clin. Oncol. 30, 943-949 (2012).
4. Raznahan, A. et al. How does your cortex grow? J. Neurosci. 31, 7174-7177 (2011).
5. Mechelli, A., Friston, K. J., Frackowiak, R. S. & Price, C. J. Structural covariance in the human cortex. J. Neurosci. 25, 8303-8310 (2005). (Pubitemid 41292125)
6. Shaw, P. et al. Intellectual ability and cortical development in children and adolescents. Nature 440, 676-679 (2006).
7. Haier, R. J., Jung, R. E., Yeo, R. A., Head, K. & Alkire, M. T. Structural brain variation and general intelligence. Neuroimage 23, 425-433 (2004). (Pubitemid 39119473)
8. Hermoye, L. et al. Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood. Neuroimage 29, 493-504 (2006). (Pubitemid 43063306)
9. Zhai, G., Lin, W., Wilber, K. P., Gerig, G. & Gilmore, J. H. Comparisons of regional white matter diffusion in healthy neonates and adults performed with a 3.0-T head-only MR imaging unit. Radiology 229, 673-681 (2003). (Pubitemid 37467568)
10. Gage, F. H. Mammalian neural stem cells. Science 287, 1433-1438 (2000). (Pubitemid 30127128)
11. Saxe, M. D. et al. Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc. Natl Acad. Sci. USA 103, 17501-17506 (2006). (Pubitemid 44788998)
12. Shors, T. J., Townsend, D. A., Zhao, M., Kozorovitskiy, Y. & Gould, E. Neurogenesis may relate to some but not all types of hippocampal-dependent learning. Hippocampus 12, 578-584 (2002). (Pubitemid 35363952)
13. Liu, J., Solway, K., Messing, R. O. & Sharp, F. R. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 18, 7768-7778 (1998). (Pubitemid 28441018)
14. Palmer, T. D., Markakis, E. A., Willhoite, A. R., Safar, F. & Gage, F. H. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J. Neurosci. 19, 8487-8497 (1999). (Pubitemid 30226767)
15. Parent, J. M. et al. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J. Neurosci. 17, 3727-3738 (1997). (Pubitemid 27200597)
16. Johnston, M. V. et al. Plasticity and injury in the developing brain. Brain Dev. 31, 1-10 (2009).
17. Huttenlocher, P. R. Basic neuroscience research has important implications for child development. Nat. Neurosci. 6, 541 (2003). (Pubitemid 36648787)
18. Kennedy, K. M. & Raz, N. Aging white matter and cognition: differential effects of regional variations in diffusion properties on memory, executive functions, and speed. Neuropsychologia 47, 916-927 (2009).
19. Middleton, F. A. & Strick, P. L. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res. Brain Res. Rev. 31, 236-250 (2000). (Pubitemid 30136179)
20. Allen, G., Buxton, R. B., Wong, E. C. & Courchesne, E. Attentional activation of the cerebellum independent of motor involvement. Science 275, 1940-1943 (1997). (Pubitemid 27148817)
21. Levisohn, L., Cronin-Golomb, A. & Schmahmann, J. D. Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain 123, 1041-1050 (2000). (Pubitemid 30224199)
22. Hayter, A. L., Langdon, D. W. & Ramnani, N. Cerebellar contributions to working memory. Neuroimage 36, 943-954 (2007). (Pubitemid 46907623)
23. Kirschen, M. P., Chen, S. H., Schraedley-Desmond, P. & Desmond, J. E. Load-and practice-dependent increases in cerebro-cerebellar activation in verbal working memory: an fMRI study. Neuroimage 24, 462-472 (2005). (Pubitemid 41359042)
24. Ravizza, S. M. et al. Cerebellar damage produces selective deficits in verbal working memory. Brain 129, 306-320 (2006). (Pubitemid 43164356)
25. Law, N. et al. Cerebello-thalamo-cerebral connections in pediatric brain tumor patients: impact on working memory. Neuroimage 56, 2238-2248 (2011).
26. Morris, E. B. et al. Proximal dentatothalamocortical tract involvement in posterior fossa syndrome. Brain 132, 3087-3095 (2009).
27. Catsman-Berrevoets, C. E. & Aarsen, F. K. The spectrum of neurobehavioural deficits in the Posterior Fossa Syndrome in children after cerebellar tumour surgery. Cortex 46, 933-946 (2010).
28. Palmer, S. L. et al. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro. Oncol. 12, 1311-1317 (2010).
29. Vaquero, E., Gómez, C. M., Quintero, E. A., González-Rosa, J. J. & Márquez, J. Differential prefrontal-like deficit in children after cerebellar astrocytoma and medulloblastoma tumor. Behav. Brain Funct. 4, 18 (2008).
30. Schmahmann, J. D. &. Sherman, J. C. The cerebellar cognitive affective syndrome. Brain 121, 561-579 (1998). (Pubitemid 28162120)
31. Di Rocco, C. et al. Preoperative and postoperative neurological, neuropsychological and behavioral impairment in children with posterior cranial fossa astrocytomas and medulloblastomas: the role of the tumor and the impact of the surgical treatment. Childs Nerv. Syst. 26, 1173-1188 (2010).
32. Charalambides, C., Dinopoulos, A. & Sgouros, S. Neuropsychological sequelae and quality of life following treatment of posterior fossa ependymomas in children. Childs Nerv. Syst. 25, 1313-1320 (2009).
33. Mulhern, R. K., Hancock, J., Fairclough, D. & Kun, L. Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med. Pediatr. Oncol. 20, 181-191 (1992).
34. Palmer, S. L. et al. Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. J. Clin. Oncol. 19, 2302-2308 (2001). (Pubitemid 32366983)
35. Schatz, J., Kramer, J. H., Ablin, A. & Matthay, K. K. Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 14, 189-200 (2000).
36. Reddick, W. E. et al. Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer 97, 2512-2519 (2003). (Pubitemid 36542491)
37. Mabbott, D. J., Penkman, L., Witol, A., Strother, D. & Bouffet, E. Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 22, 159-168 (2008). (Pubitemid 351626504)
38. Nagel, B. J. et al. Early patterns of verbal memory impairment in children treated for medulloblastoma. Neuropsychology 20, 105-112 (2006).
39. Mulhern, R. K. et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J. Clin. Oncol. 23, 5511-5519 (2005).
40. Kieffer-Renaux, V. et al. Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses. Dev. Med. Child Neurol. 42, 741-745 (2000).
41. Mulhern, R. K. et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J. Clin. Oncol. 16, 1723-1728 (1998).
42. Mabbott, D. J. et al. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J. Clin. Oncol. 23, 2256-2263 (2005). (Pubitemid 46218718)
43. Merchant, T. E. et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J. Clin. Oncol. 22, 3156-3162 (2004). (Pubitemid 41103730)
44. Merchant, T. E., Kiehna, E. N., Li, C., Xiong, X. & Mulhern, R. K. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int. J. Radiat. Oncol. Biol. Phys. 63, 1546-1554 (2005). (Pubitemid 41628055)
45. Merchant, T. E. et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int. J. Radiat. Oncol. Biol. Phys. 65, 210-221 (2006).
46. Merchant, T. E., Conklin, H. M., Wu, S., Lustig, R. H. & Xiong, X. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J. Clin. Oncol. 27, 3691-3697 (2009).
47. Hoppe-Hirsch, E. et al. Medulloblastoma in childhood: progressive intellectual deterioration. Childs Nerv. Syst. 6, 60-65 (1990). (Pubitemid 20165052)
48. Mulhern, R. K. & Palmer, S. L. Neurocognitive late effects in pediatric cancer. Curr. Probl. Cancer 27, 177-197 (2003). (Pubitemid 36876736)
49. Jalali, R. et al. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 77, 974-979 (2010).
50. Karussis, D., Leker, R. R. & Abramsky, O. Cognitive dysfunction following thalamic stroke: a study of 16 cases and review of the literature. J. Neurol. Sci. 172, 25-29 (2000). (Pubitemid 30006977)
51. Peterson, B. S. et al. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 284, 1939-1947 (2000).
52. Liu, A. K. et al. Changes in cerebral cortex of children treated for medulloblastoma. Int. J Radiat. Oncol. Biol. Phys. 68, 992-998 (2007). (Pubitemid 47048564)
53. Reeves, C. B. et al. Attention and memory functioning among pediatric patients with medulloblastoma. J. Pediatr. Psychol. 31, 272-280 (2006).
54. Mulhern, R. K., Merchant, T. E., Gajjar, A., Reddick, W. E. & Kun, L. E. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 5, 399-408 (2004). (Pubitemid 38878043)
55. Mulhern, R. K. et al. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann. Neurol. 46, 834-841 (1999).
56. Mabbott, D. J., Noseworthy, M. D., Bouffet, E., Rockel, C. & Laughlin, S. Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: correlation with IQ. Neuro. Oncol. 8, 244-252 (2006). (Pubitemid 46542649)
57. Mulhern, R. K. et al. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J. Clin. Oncol. 19, 472-479 (2001). (Pubitemid 32112861)
58. Khong, P. L. et al. White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J. Clin. Oncol. 24, 884-890 (2006).
59. Nagy, Z., Westerberg, H. & Klingberg, T. Maturation of white matter is associated with the development of cognitive functions during childhood. J. Cogn. Neurosci. 16, 1227-1233 (2004). (Pubitemid 39274449)
60. Wang, S. et al. Longitudinal diffusion tensor magnetic resonance imaging study of radiation-induced white matter damage in a rat model. Cancer Res. 69, 1190-1198 (2009).
61. Cao, Y. et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction. Clin. Cancer Res. 15, 1747-1754 (2009).
62. Kinnunen, K. M. et al. White matter damage and cognitive impairment after traumatic brain injury. Brain 134, 449-463 (2011).
63. Roosendaal, S. D. et al. Regional DTI differences in multiple sclerosis patients. Neuroimage 44, 1397-1403 (2009).
64. Abayomi, O. K. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol. 41, 346-351 (2002).
65. Nagel, B. J. et al. Abnormal hippocampal development in children with medulloblastoma treated with risk-adapted irradiation. AJNR Am. J. Neuroradiol. 25, 1575-1582 (2004). (Pubitemid 44383613)
66. Raber, J. et al. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat. Res. 162, 39-47 (2004). (Pubitemid 39044717)
67. Douw, L. et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol. 8, 810-818 (2009).
68. Conklin, H. M., Li, C., Xiong, X., Ogg, R. J. & Merchant, T. E. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J. Clin. Oncol. 26, 3965-3970 (2008).
69. Grill, J. et al. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. J. Neurosurg. 101 (2 Suppl.), 152-158 (2004). (Pubitemid 39426188)
70. Duffner, P. K. et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N. Engl. J. Med. 328, 1725-1731 (1993). (Pubitemid 23170121)
71. Merchant, T. E. et al. The effects of hydrocephalus on intelligence quotient in children with localized infratentorial ependymoma before and after focal radiation therapy. J. Neurosurg. 101 (2 Suppl.), 159-168 (2004). (Pubitemid 39426189)
72. Hardy, K. K., Bonner, M. J., Willard, V. W., Watral, M. A. & Gururangan, S. Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma. Psychooncology 17, 1157-1161 (2008).
73. Reimers, T. S. et al. Cognitive deficits in long-term survivors of childhood brain tumors: identification of predictive factors. Med. Pediatr. Oncol. 40, 26-34 (2003). (Pubitemid 35340564)
74. Duffner, P. K. Risk factors for cognitive decline in children treated for brain tumors. Eur. J. Paediatr. Neurol. 14, 106-115 (2010).
75. Mahoney, D. H. Jr et al. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. J. Clin. Oncol. 16, 246-254 (1998). (Pubitemid 28041605)
76. Riva, D. et al. Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology 59, 48-53 (2002). (Pubitemid 34742793)
77. Meador, K. J. Cognitive outcomes and predictive factors in epilepsy. Neurology 58, S21-S26 (2002). (Pubitemid 34415367)
78. Mula, M. & Trimble, M. R. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs 23, 121-137 (2009).
79. Wu, T. et al. Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study. Epilepsy Behav. 16, 468-474 (2009).
80. Ryan, R., Booth, S. & Price, S. Corticosteroid-use in primary and secondary brain tumour patients: a review. J. Neurooncol. 106, 449-459 (2012).
81. Wolkowitz, O. M., Lupien, S. J., Bigler, E., Levin, R. B. & Canick, J. The "steroid dementia syndrome": an unrecognized complication of glucocorticoid treatment. Ann. N. Y. Acad. Sci. 1032, 191-194 (2004). (Pubitemid 40298473)
82. Damsted, S. K., Born, A. P., Paulson, O. B. & Uldall, P. Exogenous glucocorticoids and adverse cerebral effects in children. Eur. J. Paediatr. Neurol. 15, 465-477 (2011).
83. Gondi, V. et al. Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 78, 1244-1252 (2010).
84. Marsh, J. C., Gielda, B. T., Herskovic, A. M. & Abrams, R. A. Cognitive sparing during the administration of whole brain radiotherapy and prophylactic cranial irradiation: current concepts and approaches. J. Oncol. 2010, 198-208 (2010).
85. Carrie, C. et al. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98. J. Clin. Oncol. 27, 1879-1883 (2009).
86. Gandola, L. et al. Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J. Clin. Oncol. 27, 566-571 (2009).
87. Prados, M. D. et al. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. Int. J. Radiat. Oncol. Biol. Phys. 43, 279-285 (1999). (Pubitemid 29091465)
88. St Clair, W. H. et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int. J. Radiat. Oncol. Biol. Phys. 58, 727-734 (2004). (Pubitemid 38221128)
89. Miralbell, R., Lomax, A., Cella, L. & Schneider, U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int. J. Radiat. Oncol. Biol. Phys. 54, 824-829 (2002).
90. Barnett, G. C. et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol. 13, 65-77 (2012).
91. West, C. et al. Establishment of a Radiogenomics Consortium. Int. J. Radiat. Oncol. Biol. Phys. 76, 1295-1296 (2010).
92. Monje, M. L., Mizumatsu, S., Fike, J. R. & Palmer, T. D. Irradiation induces neural precursor-cell dysfunction. Nat. Med. 8, 955-962 (2002). (Pubitemid 35033699)
93. Monje, M. L. et al. Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Ann. Neurol. 62, 515-520 (2007). (Pubitemid 350308776)
94. Monje, M. L., Toda, H. & Palmer, T. D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760-1765 (2003). (Pubitemid 37505739)
95. Yazlovitskaya, E. M. et al. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res. 66, 11179-11186 (2006). (Pubitemid 46009945)
96. Yang, E. S. et al. Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice. J. Clin. Invest. 119, 1124-1135 (2009).
97. Ramanan, S. et al. The PPARα agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation. Int. J. Radiat. Oncol. Biol. Phys. 75, 870-877 (2009).
98. Pasquier, E., Kavallaris, M. & Andre, N. Metronomic chemotherapy: new rationale for new directions. Nat. Rev. Clin. Oncol. 7, 455-465 (2010).
99. Halliwell, B. & Aruoma, O. I. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett. 281, 9-19 (1991).
100. Rola, R. et al. High-LET radiation induces inflammation and persistent changes in markers of hippocampal neurogenesis. Radiat. Res. 164, 556-560 (2005). (Pubitemid 41368936)
101. Hirsch, C. Continued use of antipsychotic drugs increased long-term mortality in patients with Alzheimer disease. Evid. Based Med. 14, 115 (2009).
102. Kuzumaki, N. et al. Hippocampal epigenetic modification at the doublecortin gene is involved in the impairment of neurogenesis with aging. Synapse 64, 611-616 (2010).
103. Manda, K., Ueno, M. & Anzai, K. Cranial irradiation-induced inhibition of neurogenesis in hippocampal dentate gyrus of adult mice: attenuation by melatonin pretreatment. J. Pineal Res. 46, 71-78 (2009).
104. Kilic, E. et al. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J. Pineal Res. 45, 142-148 (2008).
105. Ramirez-Rodriguez, G., Klempin, F., Babu, H., Benítez-King, G. & Kempermann, G. Melatonin modulates cell survival of new neurons in the hippocampus of adult mice. Neuropsychopharmacology 34, 2180-2190 (2009).
106. Berridge, C. W. et al. Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α1-and α2-receptors. Biol. Psychiatry 71, 467-473 (2012).
107. Brown, R. T. et al. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics 115, e749-e757 (2005). (Pubitemid 43843150)
108. Cooper, M. R., Bird, H. M. & Steinberg, M. Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Ann. Pharmacother. 43, 721-725 (2009).
109. Shaw, E. G. et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J. Clin. Oncol. 24, 1415-1420 (2006). (Pubitemid 46622007)
110. Lee, J. K. et al. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 28, 329-343 (2010).
111. Venkataramana, N. K. et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl. Res. 155, 62-70 (2010).
112. Kim, Y. J. et al. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 57, 13-23 (2009).
113. Munoz, J. R. et al. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl Acad. Sci. USA 102, 18171-18176 (2005). (Pubitemid 41798520)
114. Acharya, M. M. et al. Human neural stem cell transplantation ameliorates radiation-induced cognitive dysfunction. Cancer Res. 71, 4834-4845 (2011).
115. Deisseroth, K. et al. Excitation-neurogenesis coupling in adult neural stem/progenitor cells. Neuron 42, 535-552 (2004). (Pubitemid 38639875)
116. Reeves, C. B. et al. Brief report: sluggish cognitive tempo among pediatric survivors of acute lymphoblastic leukemia. J. Pediatr. Psychol. 32, 1050-1054 (2007). (Pubitemid 47622300)
117. Searle, N. S., Askins, M. & Bleyer, W. A. Homebound schooling is the least favorable option for continued education of adolescent cancer patients: a preliminary report. Med. Pediatr. Oncol. 40, 380-384 (2003). (Pubitemid 36514441)
118. Hassler, M. R. et al. Neurocognitive training in patients with high-grade glioma: a pilot study. J. Neurooncol. 97, 109-115 (2010).
119. Locke, D. E. et al. Cognitive rehabilitation an patients with primary brain tumors: a pilot study. J. Support. Oncol. 6, 383-391 (2008).
120. Gehring, K. et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J. Clin. Oncol. 27, 3712-3722 (2009).
121. Butler, R. W. et al. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J. Consult. Clin. Psychol. 76, 367-378 (2008). (Pubitemid 351822338)
122. Brockmann, S. et al. Reorganization of functional areas of the brain after brain irradiation. J. Clin. Oncol. 29, e321-e323 (2011).
123. Luo, C. X. et al. Voluntary exercise-induced neurogenesis in the postischemic dentate gyrus is associated with spatial memory recovery from stroke. J. Neurosci. Res. 85, 1637-1646 (2007).
124. van Praag, H. et al. Exercise enhances learning and hippocampal neurogenesis in aged mice. J. Neurosci. 25, 8680-8685 (2005). (Pubitemid 41362045)
125. Yaffe, K., Barnes, D., Nevitt, M., Lui, L. Y. & Covinsky, K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch. Intern. Med. 161, 1703-1708 (2001). (Pubitemid 32679544)
126. Wong-Goodrich. S. J. et al. Voluntary running prevents progressive memory decline and increases adult hippocampal neurogenesis and growth factor expression after whole-brain irradiation. Cancer Res. 70, 9329-9338 (2010).
127. West, C. M. & Barnett, G. C. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med. 3, 52 (2011).
128. Ciccolini, J., Mercier, C., Dahan, L. & André, N. Integrating pharmacogenetics into gemcitabine dosing-time for a change? Nat. Rev. Clin. Oncol. 8, 439-444 (2011).
129. Barnett, G. C. et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat. Rev. Cancer 9, 134-142 (2009).
130. Andreassen, C. N. & Alsner, J. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother. Oncol. 92, 299-309 (2009).
131. Iannuzzi, C. M., Atencio, D. P., Green, S., Stock, R. G. & Rosenstein, B. S. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int. J. Radiat. Oncol. Biol. Phys. 52, 606-613 (2002). (Pubitemid 34158720)
132. Barahmani, N. et al. Glutathione S transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma. Neuro. Oncol. 11, 292-300 (2009).
133. Best, T. et al. Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nat. Med. 17, 941-943 (2011).
134. Kerns, S. L. et al. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 78, 1292-1300 (2010).